HEALTHCARE

09 Feb 2016

Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide

Ferring Pharmaceuticals announced today the commencement of the Phase 3b PRONOUNCE Trial. The trial will compare the occurrence of major adverse cardiovascular events (MACEs) in patients with prostate cancer and cardiovascular disease (CVD), receiving the GnRH receptor antagonist, degarelix,"...

Continue Reading

08 Feb 2016

Astrazeneca’s Combination of Durvalumab with Tremelimumab Shows Clinical Activity in Non-Small Cell Lung Cancer Irrespective Of Pd-L1 Status

Lancet Oncology reports Phase Ib study (study 006) of combined PD-L1 and CTLA-4 checkpoint inhibitors in locally advanced or metastatic NSCLC

Early results support AstraZeneca’s combination strategy in immuno-oncology with potential combination efficacy for patients with PD-L1 negative NSCLC

......

Continue Reading

08 Feb 2016

Egypt’s health ministry says female genital mutilation will end by 2030

After being delivered a message from UN General Ban Ki-moon on the International Day of Zero Intolerance to Female Genital Mutilation, Egypt’s Health Minister Ahmed Emad Eddine said"...

Continue Reading

07 Feb 2016

Egypt: Matariya Doctors Threaten to Submit Mass Resignations

Doctors at Matariya Teaching Hospital decided Friday to submit their resignation to the Minister of Health if alleged police assault on doctors is not investigated.


The Matariya doctors said they will resume work at the reception and emergency departments of the hospital despite not having had their "rights" given"......

Continue Reading

06 Feb 2016

Quintiles Wins 2016 Leadership Excellence Award

Quintiles, the world’s largest biopharmaceutical services company, has been awarded the HR.com 2016 Leadership Excellence Award for Innovation in Deployment of Leadership Programs.


HR.com,"...

Continue Reading

05 Feb 2016

In New Clinical Study Masimo’s Oxygen Reserve Index Helps Clinicians Detect Impending Desaturation in Pediatric Patients

Masimo (NASDAQ: MASI) announced today that in a new clinical study, Masimo’s Oxygen Reserve Index (ORI™), the first noninvasive and continuous parameter to provide insight into patients’ oxygen reserve when they are receiving supplemental oxygen, helped clinicians in the early identification of impending desaturation in pediatric"......

Continue Reading

05 Feb 2016

IMS Health Acquires Dimensions Healthcare LLC in the United Arab Emirates

IMS Health (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced completion of its acquisition of Dimensions Healthcare, a United Arab Emirates (UAE) company which provides high quality healthcare systems"...

Continue Reading

04 Feb 2016

NAMSA Announces Divestiture of its Sterility Assurance Products Division

North American Science Associates, Inc. (NAMSA), the world’s leading medical research organization (MRO®) today announced a definitive agreement to divest its Sterility Assurance Products Division of biological and chemical indicators. Crosstex International, Inc. (Crosstex),"...

Continue Reading

04 Feb 2016

SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents

  • SPIRIVA® RESPIMAT® is the first new class of inhaled medicine approved in over 10 years for the treatment of asthma1
  • Despite current treatment options almost one in two patients with asthma still experience symptoms,2,3,4 increasing their risk of asthma exacerbations5

"...

Continue Reading

04 Feb 2016

The Health Industry Summit Stirs Investor Frenzy Over China’s Healthcare Sector With Double-Digit Growth

In the summer of 2015, an event drew record-breaking single-day crowds of over 170,000 professionals to Shanghai solely for the healthcare sector. It was a mega trade event combining the top medical and pharmaceutical events in China, the Health Industry Summit.


...

Continue Reading
Found articles: 32 - Pages  1 2 3 4 
Contact US | Powered by CNPHUB.com - All Rights Reserved